Mankind Pharma Assigned ESG Rating of 71 by NSE Sustainability for FY26
Mankind Pharma Ltd 路 Others (Uncategorized) 路 16 Oct 2026, 2:08 am
Mankind Pharma Assigned ESG Rating of 71 by NSE Sustainability for FY26 Mankind Pharma Limited has been assigned an Environmental, Social, and Governance (ESG) rating of '71' by NSE Sustainability Ratings and Analytics Limited for FY26. The rating was independently assigned by the SEBI-registered ESG rating provider based on publicly available information, without direct engagement from the company.
Original exchange filing (PDF)
More announcements from Mankind Pharma Ltd
- Please find attached intimation regarding change in Corporate Office Address of RTA 路 13 Nov 2026
- Please find attached Intimation of participation in the Investor Conference 路 06 Nov 2026
- Please find attached intimation regarding ESG Rating 路 05 Nov 2026
- Intimation of participation in the Investor Conference. 路 03 Nov 2026
- Please find attached transcript of the Earnings Conference Call for Q2 & H1 FY27 路 30 Oct 2026
- Please find attached intimation regarding re-affirmation/withdrawl of Credit Rating by CRISIL 路 30 Oct 2026
- In continuation of our earlier intimation dated October 22, 2026 please find attached the Investor Presentation to be made during the said Analyst / Institutional Investors meet 路 27 Oct 2026
- Please find attached link for audio recording of the Investor Conference Call held on October 26, 2026 路 27 Oct 2026
